NanoString Technologies Company

NanoString Technologies provides a life science tools platform for a variety of basic research, translational medicine and IVD applications.
Technology: Genetic Test & Molecular Diagnostics
Industry: Omic
Headquarters: Seattle, Washington, United States
Founded Date: 2003-01-01
Employees Number: 251-500
Funding Status: IPO
Investors Number: 13
Total Funding: $731,350,000.00
Estimated Revenue: $10M to $50M
Last Funding Date: 2020-10-13
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership